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Andrew G Lum1, Melissa Ly1, Tasha M Santiago-Rodriguez1, Mayuri Naidu1, Tobias K Boehm2
and David T Pride1,3*Abstract
Background: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPRs) are active in acquired resistance
against bacteriophage and plasmids in a number of environments. In the human mouth, CRISPR loci evolve to
counteract oral phage, but the expression of these CRISPR loci has not previously been investigated. We sequenced
cDNA from CRISPR loci found in numerous different oral bacteria and compared with oral phage communities to
determine whether the transcription of CRISPR loci is specifically targeted towards highly abundant phage present
in the oral environment.
Results: We found that of the 529,027 CRISPR spacer groups studied, 88 % could be identified in transcripts,
indicating that the vast majority of CRISPR loci in the oral cavity were transcribed. There were no strong associations
between CRISPR spacer repertoires and oral health status or nucleic acid type. We also compared CRISPR repertoires
with oral bacteriophage communities, and found that there was no significant association between CRISPR transcripts
and oral phage, regardless of the CRISPR type being evaluated. We characterized highly expressed CRISPR spacers and
found that they were no more likely than other spacers to match oral phage. By reassembling the CRISPR-bearing reads
into longer CRISPR loci, we found that the majority of the loci did not have spacers matching viruses found in the oral
cavities of the subjects studied. For some CRISPR types, loci containing spacers matching oral phage were significantly
more likely to have multiple spacers rather than a single spacer matching oral phage.
Conclusions: These data suggest that the transcription of oral CRISPR loci is relatively ubiquitous and that highly
expressed CRISPR spacers do not necessarily target the most abundant oral phage.
Keywords: CRISPR, Microbiome, Oral microbiome, Virome, VirusBackground
Bacteriophage and plasmids have a significant capacity to
alter the ecology of bacterial and archaeal communities
[1–4]. Whether lytic phage lyse their bacterial hosts or ly-
sogenic phage and plasmids provide them with potentially
beneficial gene functions [5, 6], the presence of these mo-
bile genetic elements are important drivers of ecosystem
diversity in a number of environments [7–9]. Despite their
sometimes beneficial effects upon their hosts, many bac-
teria and archaea have multiple mechanisms by which to
counteract phage and plasmids [10–13]; thus reducing* Correspondence: dpride@ucsd.edu
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unless otherwise stated.their potential to perturb microbial communities. In many
bacteria and archaea, adaptive immunity has evolved,
where exposures to certain phage and plasmids result in
the insertion of short sequences into the host chromo-
some [14]. These ‘spacers’ are then utilized via nucleic
acid interference to resist future encounters with the
same phage/plasmids or other phage/plasmids with
similar sequences [15–17]. These spacers are interspersed
between palindromic repeat motifs to form the CRISPR
(Clustered Regularly Interspaced Short Palindromic
Repeats) locus. These loci, along with a related set of host
CRISPR Associated [18] genes form the CRISPR-Cas sys-
tem [19–21].
Phage generally outnumber their bacterial hosts by a
10:1 ratio in many human specimen types, and that ratio
generally increases when they are attached to mucosal sur-
faces [22]. Relative to their bacterial hosts, there are faris is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and responses to perturbations in human phage commu-
nities [23–26]. In the human gut [27] and the human oral
cavity [23], there is evidence that phage are highly persist-
ent members of these ecosystems. This suggests that ei-
ther the host organisms are incapable of utilizing CRISPRs
to eradicate these viruses from the ecosystem, or that a dy-
namic equilibrium between host and phage has developed
that may include CRISPR-mediated resistance mechanisms.
Prior studies have demonstrated that phage typically coexist
with CRISPR spacers that match their sequences in the hu-
man oral cavity [28, 29] and other environments [30]. Local
phage populations respond to the presence of matching
CRISPR spacers in a number of environments [31, 32], but
these dynamics have not been thoroughly explored in
complex human specimens types. In human periodontal
disease, phage communities are noted to be significantly al-
tered compared to periodontally healthy subjects [33].
Whether there may be a role for CRISPRs in the cellular
microbiota in helping to shape these differences amongst
the periodontal microbiota has not previously been ex-
plored. There are substantial repertoires of CRISPR spacers
in human saliva [11], dental plaque [34], skin [35], and the
GI tract [36]; however, the expression of these CRISPR
spacers has yet to be examined.
Studies of the distribution of CRISPR spacers in hu-
man subjects have revealed that despite a fair number
shared between individuals, they are highly individual-
specific [35]. In addition to subject-specificity, CRISPR
spacers vary according to biogeographic sites sampled
[28, 34]. There are numerous shared spacers between
dental plaque and saliva in the oral cavities of individual
subjects; however, each site has its own distinct biogeog-
raphy. Many of the CRISPR spacers found on different
body surfaces are highly conserved over time [35], as ev-
idenced by the large proportion of spacers conserved
longitudinally on human skin and in saliva. Much of the
conservation of CRISPR spacers likely is due to the per-
sistence of the bacteria harboring them on these body
surfaces. Despite having significant differences in their
bacterial ecology, many CRISPR spacers in the human
mouth are identical to those found on human skin [35],
which suggests that both body sites are exposed to
similar viruses; however, some CRISPRs on both body
surfaces are probably acquired through either vertical
or horizontal transmission. Individuals living together
share a significant proportion of their CRISPR spacers
when compared to control individuals from different
living environments, which likely reflects a combin-
ation of shared viral exposures and shared bacterial
biota within a household [29]. We hypothesize that
many of these CRISPR loci are actively transcribed and
may be involved in acquired resistance against oral bac-
teriophage; however, the activity of CRISPR loci has notpreviously been evaluated on a global scale on human
body surfaces.
CRISPR loci are transcribed as a single, long RNA pre-
cursor that is processed to generate CRISPR RNAs
(crRNAs). Transcription is generally unidirectional, and
initiates at the end of the locus that contains the leader
sequence [17]. Cas proteins are necessary for the processing
of the long CRISPR transcript, but the regulation of Cas
genes is likely to differ according to bacterial species or
strain [37, 38]. CRISPR-Cas-mediated resistance then gen-
erally proceeds in three stages in the CRISPR-Cas systems
described thus far [39]. In the first stage, Cas proteins
recognize and cleave exogenous sequences and incorporate
them next to cas genes; the second stage involves the tran-
scription of crRNAs, and the third stage involves the inter-
ference mechanism [21]. Type II CRISPR-Cas systems have
been well characterized in Streptococcus thermophilus [40],
and consist of cas1, cas2, cas9 and either csn2 or cas4 [39].
Several studies of CRISPRs in the human oral cavity have
characterized Type II CRISPR-Cas systems, alternatively
known as SGI and SGII CRISPRs based on their repeat
motif sequences in streptococcal species [11, 28, 29, 34, 35].
Cas1 and Cas2 are universal among the CRISPR-Cas sys-
tems and the others are unique to the Type II CRISPR-Cas
system [41, 42]. Cas9 degrades foreign DNA and functions
in crRNA biogenesis [43], and Csn2 and Cas4 are import-
ant for new spacer acquisition in Type II-A, and type II-B
CRISPR-Cas systems, respectively [44, 45]. While CRISPR-
Cas transcription mechanisms have been characterized in
environmental settings and various bacteria/bacteriophage
models [30, 46, 47], transcription of CRISPR loci has not
been evaluated in human ecosystems. Many bacteria and
archaea in these environments may also harbor CRISPR
loci that are inactive [19, 48–53], which may occur at the
level of transcription of the CRISPR locus or the expression
of Cas genes.
Here, we sought to characterize CRISPR loci at the com-
munity level in human saliva to decipher whether CRISPR
locus transcription is targeted towards highly abundant
oral phage. Because we amplify and sequence spacers be-
longing to CRISPR loci based on their repeat motifs, we
can simultaneously characterize hundreds of different
CRISPR loci belonging to different oral bacteria [29]. In
our prior studies of oral CRISPRs, we have found that the
proportion of CRISPR spacers that matched oral phage
was relatively low. Due to the high numbers of CRISPR
loci that we can identify and the low proportion of match-
ing oral phage, we hypothesized that the proportion of
CRISPR loci identified in the oral cavity that are expressed
as transcripts would be low. The goals of this study were
to compare the CRISPR repertoires found in genomic
DNA with those present in mRNA in a cohort of human
subjects, examine whether biases exist in CRISPR reper-
toires that may be characteristic of oral health status,
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scribed, develop methods for assembly of CRISPR loci
from short sequence reads, identify highly expressed
CRISPR spacers, and to determine whether the transcrip-
tion of CRISPR loci may be regulated by the presence of
highly abundant oral viruses.
Results
CRISPR spacer sequencing
We recruited 16 human subjects and sampled their sal-
iva. Nine of the subjects were in good overall periodon-
tal health and 7 had significant periodontal disease. We
amplified and sequenced CRISPR spacers by utilizing
their direct repeat motifs as targets for the primer se-
quences. The benefit of such a technique is that we can
amplify CRISPR spacer sequences from a wide array of
different bacterial species that share the same repeat
motifs, while the primary limitation is that we cannot
ascribe the spacer sequences to any given bacterial spe-
cies or strain. We sequenced SGI and SGII CRISPR
spacers (both are Type II CRISPR-Cas systems) that have
previously been identified primarily in various species of
Streptococcus, GHI spacers identified in Gemella haemo-
lysans, and VSI spacers identified in Veillonella species
[28, 35]. GHI and VSI CRISPR repeat motifs have not
previously been assigned to CRISPR-Cas system types.
We previously have shown that there are robust reper-
toires of each of these CRISPR spacer types in a larger
group of human subjects [29]. Each spacer type likely is
present in multiple different oral bacteria species. From
the DNA of each subject, we sequenced 224,896 SGI
CRISPR spacers (mean of 14,056 per subject), 282,903
SGII spacers (mean of 17,681 per subject), 397,687 GHI
spacers (mean of 24,855 per subject), and 463,368 VSI
spacers (mean of 28,961 per subject) (Additional file 1:
Table S1). We also sequenced CRISPR spacers from the
mRNA of each subject to determine whether CRISPR
spacers present in each subject were transcribed. From the
cDNA, we sequenced 219,113 spacers SGI spacers (mean
of 13,695 per subject), 195,316 SGII spacers (mean of
12,207 per subject), 352,071 GHI spacers (mean of 22,004
per subject), and 303,764 VSI spacers (mean of 18,985 per
subject).
Spacer binning and estimated coverage
We binned the spacer sequences according to our previ-
ously described protocols based on their trinucleotide
content to correct for potential sequencing errors as well
as to group highly similar spacer sequences [29]. Similar
to data utilizing a different group of subjects, the vast
majority of CRISPR spacers from each spacer type was
identical and did not necessitate grouping according to
trinucleotide content. The estimated polymorphism rate
among the spacers was 0.001 % for SGI spacers, 0.002 %for SGII spacers, 0.003 % for GHI spacers, and 0.003 %
for VSI spacers (Additional file 2: Figure S1). We next
performed rarefaction analysis on the resulting spacer
groups to get an estimate of the spacer richness in each
subject or group of subjects and to determine whether
the majority of the spacer sequences had been sampled.
We found that for most subjects and CRISPR spacer types
the curves reached asymptote, indicating that further
sequencing would not have revealed many new spacer se-
quences (Additional file 2: Figure S2, Panels A-D). For
SGII spacers, there generally was higher spacer richness,
and fewer of the curves reached asymptote. There was no
substantial association between oral health status and
CRISPR spacer richness for SGI spacers (Panel A), SGII
spacers (Panel B), or VSI spacers (Panel D); however, there
was a trend towards lower spacer richness for GHI spacers
in subjects with periodontal disease (Panel C). Nucleic
acid type was not associated with CRISPR spacer richness,
as regardless of CRISPR spacer type, curves were similar
in each subject for those spacers identified from DNA and
those identified from cDNA (Panels A-D).
CRISPR spacer distribution by subject and oral health
status
We next characterized the distribution of CRISPR
spacers amongst each subject and nucleic acid type to
determine whether there were CRISPR spacers more
likely to be present or transcribed by oral health status.
The majority of the SGI (Fig. 1, Panel A), SGII (Panel B),
GHI (Panel C), and VSI (Panel D) CRISPR spacers ap-
pear to be subject specific rather than specific to oral
health status when examining CRISPR spacer distribu-
tion by heatmap. We quantified the proportions of
CRISPR spacers shared amongst subjects with periodon-
tal health or disease and found that 13.5 % of SGI
spacers, 12.8 % of SGII spacers, 21.1 % of GHI spacers,
and 12.5 % of VSI spacers were shared between subjects
with relative periodontal health (Additional file 1: Table
S2); none of these values were significantly different
from the proportion of spacers shared in periodontal
disease or the proportion shared between subject groups.
The vast majority of the spacers in each subject were in-
dividual specific, and those 10-15 % that were shared be-
tween different subjects were largely shared with only 1
other subject for all spacer types (Fig. 2, Panels A-D).
There were few spacers that were shared between 2 or
more subjects and no specific patterns observed of spa-
cer sharing between subjects with relative periodontal
health and disease. When measuring the relative propor-
tion of CRISPR spacers shared within a subject versus
those shared with other subjects, we found that in nearly
all subjects and CRISPR spacer types, the CRISPR spacer
repertoires were significantly (p < 0.05) subject specific
(Additional file 1: Table S3).
Fig. 1 Heatmaps of CRISPR spacer groups in all subjects and nucleic acid types. Each row represents a unique spacer group and the columns are
labeled by each individual subject. For each subject, CRISPR spacers derived from genomic DNA are located on the left and CRISPR spacers
derived from cDNA are located on the right. Panel A—SGI CRISPR spacers, Panel B—SGII CRISPR spacers, Panel C—GHI CRISPR spacers, and Panel
D—VSI CRISPR spacers
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Many of the CRISPR spacers identified in each subject
appeared to also be present in transcripts for most sub-
jects and CRISPR types (Fig. 1). We quantified the pro-
portion of CRISPR spacers in each subject that were
present in the DNA, but also were found in transcripts
(Fig. 3, Panel A). The vast majority of all CRISPR spacers
identified also were transcribed, with 95.4 ± 11.7 % of
SGII spacers found in both the DNA and RNA fractions,
while 4.6 ± 2.5 % were found in the DNA fractions alone.
Similar results were identified for SGI (88.4 ± 8.2 % present
in both), GHI (86.7 ± 7.4 % present in both), and VSI
(79.6 ± 11.5 % present in both) spacers, indicating that
the vast majority of the CRISPR spacers were transcribed.
The proportions of spacers shared in the DNA and cDNA
fractions were significantly subject specific (p < 0.05) in
nearly all subjects and CRISPR types (Additional file 2:
Figure S3). There was no association between the CRISPR
spacer repertoires of different subjects based on whether they
were transcribed or not, as evidenced by the 8.9 % of SGI
spacers, 9.9 % of SGII spacers, 15.4 % of GHI spacers, and
10.4 % of VSI spacers that were shared between different
subjects in the cDNA fractions. These relative proportionswere similar to those shared in the DNA fractions between
different subjects, and none of the differences were signifi-
cant based on nucleic acid type (Additional file 1: Table S2).
Matches to virome reads
We previously sequenced the viromes from the saliva of
each subject involved in this study [33]. We compared
the relative proportions of the CRISPR spacer reper-
toires of each CRISPR spacer type that matched virome
reads to determine whether spacers that are transcribed
may be targeted towards the most abundant viruses
present in the oral cavity. We measured the proportions
of CRISPR spacers matching virome reads for those that
were transcribed (found in DNA and RNA fractions),
and those that were not transcribed (found in the DNA
fraction only). Because the proportion of spacers matching
phage within the same subject was relatively low in this
study and in prior studies of oral CRISPR/Phage interac-
tions [28, 29, 34, 35], we pooled the virome reads to iden-
tify matches to phage known to be present in the oral
cavity of our cohort. There were no significant trends or
differences between transcribed spacers and those spacers
not transcribed in their relative proportions that matched
Fig. 2 Bar graphs representing the percentages of shared spacers across all subjects and spacer types. Spacers shared when all subjects are
compared are shown in gray, when only subjects with periodontal health are compared are shown in white, when only subjects with periodontal
disease are compared are shown in black, and for comparisons between subjects with periodontal health and disease are shown in red. The y-axis
represents the percentage of spacers shared, and the x-axis represents the number of different subjects sharing spacers. The bars representing ‘1’ are
unique to individual subjects, and ‘2’ represents spacers shared by only 2 different subjects, and so on. Few spacers across all spacer types are shared in
more than 2 different subjects. Panel A—SGI CRISPR spacers, Panel B—SGII CRISPR spacers, Panel C—GHI CRISPR spacers, and Panel D—VSI
CRISPR spacers
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transcribed SGII CRISPR spacers matched virome
reads, while 12 % of the spacers that were not tran-
scribed matched virome reads; a difference that was not
statistically significant. We also tested whether there
was an association between the spacers that matched
the virome reads based on the oral health status of each
subject. We observed mostly subject specific patterns of
spacers that matched virome reads for SGI and SGII
spacers (Additional file 2: Figure S4), and no associa-
tions were observed based on periodontal health status
for any of the spacer types evaluated (Additional file 2:
Figure S5).Identification of highly expressed spacers
We normalized spacer values according to their Percent-
age Per Thousand Spacers (PPTS) so that we could dir-
ectly compare their proportions across DNA and cDNA.
The relative abundances of spacers in the DNA fraction
were used as baseline expression values and compared
to relative abundances in cDNA to determine whether
some spacers were highly expressed. We then utilized a
rank correlation method based on the PPTS values to
characterize how well the relationship between the base-
line expression and the expression values in the cDNA
were correlated. For most subjects and spacer types,
there was a substantial correlation between the baseline
Fig. 3 Percentage (±standard deviation) of spacers from each CRISPR spacer type that are transcribed for all subjects (Panel A), and the
percentage of spacers that match virome reads (Panel B). Transcribed spacers are shown in white and those not identified in transcripts are
shown in black
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Panel A and Additional file 2: Figures S6, S7, S8 and S9),
which suggested that relatively few spacers had signifi-
cantly altered expression. We calculated Spearman’s rho
values to describe the degree of correlation between the
expression values. In general, values ranging from 0.6
to 1.0 are considered strong correlations, values of 0.4 to
0.6 are considered moderate, and values below 0.4 are con-
sidered weak. Most values exceeded 0.6 for all spacer types,
while only a couple of values indicated weak correlations
(Table 1). For example, SGI spacers for subject H1 had a
high degree of correlation with a rho value of 0.87 (Fig. 4,
Panel A), while there were quite a few SGI spacers in sub-
ject H7 that appeared to be highly expressed with a rho
value of 0.42 (Panel B). To decipher whether those spacersFig. 4 Plots of PPTS (Percentage Per Thousand Spacers) values from the DN
PPTS values are shown on the y-axis and the individual spacers are shown
spacer. Spearman’s rho values are represented above the curves. PPTS valu
by the arrows. Panel A represents SGI spacers for subject H1 and Panel B rthat appeared to be highly expressed were actually highly
expressed, we calculated residual values between the PPTS
in the DNA and the cDNA and defined those spacers with
residual values greater than 3x the baseline expression as
highly expressed. Spacers that met this definition of high
expression represented approximately 9-11 % of the
spacers repertoires evaluated across all subjects and
CRISPR types (Additional file 2: Figure S10). We next
evaluated whether those spacers that were highly
expressed were more likely to match oral phage from the
subjects studied. There were no significant differences
identified in the proportions of spacers matching virome
reads regardless of whether they were highly expressed or
not (Fig. 5, Panel A). There was a trend towards more of
the highly expressed SGI and SGII spacers matchingA fractions (black diamonds) and the cDNA fractions (red boxes). The
on the x-axis. Each box or diamond represents a different individual
es that differ significantly between DNA and cDNA fractions are shown
epresents SGI spacers for subject H7
Table 1 Spearman rho values for all DNA/cDNA comparisons
DNA vs cDNA CRISPR spacer comparisons
Subject SGI SGII GHI VSI
H1 0.87 0.77 0.85 0.53
H2 0.89 0.65 0.55 0.70
H3 0.71 0.87 0.91 0.83
H4 0.90 0.87 0.88 0.82
H5 0.70 0.87 0.77 0.77
H6 0.85 0.85 0.81 0.86
H7 0.42a 0.79 0.67 0.53
H8 0.85 0.85 0.89 0.61
H9 0.84 0.88 0.84 0.72
D1 0.57 0.88 0.82 0.46
D2 0.61 0.93 0.84 0.84
D3 0.56 0.70 0.87 0.82
D4 0.53 0.87 0.58 0.84
D5 0.87 0.80 0.57 0.75
D6 0.80 0.86 0.93 0.59
D7 0.80 0.83 0.83 0.79
arho values <0.5 are indicated in bold
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were not statistically significant (Panel B).
CRISPR locus assembly technique
Because of the significant number of SGI and SGII
CRISPR spacers that matched virome reads from the
subjects (Fig. 3, Panel B), we developed a method to as-
semble CRISPR loci from each subject to determine
whether certain loci had multiple spacers that matched
oral phage. To assemble CRISPR loci, we re-sequenced
all the SGI and SGII CRISPR spacers from each subject
using longer read technology, where the average read
length was approximately 200 bp and contained multiple
spacers compared to the shorter reads (average length of
100 bp) used to characterize the CRISPR spacer reper-
toires. From the DNA of each subject, we sequenced
264,749 SGI spacers (mean of 16,547 per subject) and
310,953 SGII CRISPR spacers (mean of 19,435 per sub-
ject) (Additional file 1: Table S4). From the cDNA, we
sequenced 375,625 SGI spacers (mean of 23,477 per sub-
ject) and 327,748 SGII CRISPR spacers (mean of 20,484
per subject). We binned the spacers from each sequence
read according to their trinucleotide content to account for
the potential for sequencing errors, and assigned each spa-
cer a unique identifier (Fig. 6). We then compared the reads
within each subject by nucleic acid type to reassemble
CRISPR loci based on their overlapping adjacent spacers.
Only spacer combinations that were present in 60 % of the
reads were utilized to reconstruct CRISPR loci, while reads
that had similar CRISPR spacers within a subject with theirorder altered were discarded, as they may represent lesser
abundant CRISPR loci or could occur from PCR amplifica-
tion artifacts. We validated that the technique is capable of
reconstructing CRISPR loci by PCR amplifying and sequen-
cing the entire reconstructed locus using traditional Sanger
sequencing (Additional file 2: Figures S11 and S12).Analysis of CRISPR loci
We binned the SGI spacers from DNA into 3,045 spacer
groups and the SGII spacers into 3,268 spacer groups.
From the cDNA, we binned the SGI spacers into 3,200
spacer groups and the SGII spacers into 3,219 spacer
groups. We performed rarefaction analysis on each subject
and nucleic acid type for SGI (Additional file 2: Figure
S13, Panel A) and SGII (Panel B) to determine whether
the CRISPR spacers had been thoroughly sampled. In each
case, the rarefaction curves reached asymptote, indicating
that further sequencing would not have identified many
more CRISPR spacers in each subject. The relative spacer
richness estimates were lower for the longer reads than
for the short-read sequencing (Additional file 2: Figure S2)
because short reads that likely contained orphan spacers
were not included in this analysis.
After assembly, we quantified the metrics of the result-
ing CRISPR loci. From the cDNA for SGI CRISPRs, the
mean number of loci was 23.6 per subject with an aver-
age of 5.8 spacers per locus (Additional file 1: Table S5).
Similar results were found in the DNA for SGI CRISPRs
with a mean of 21.7 loci per subject with an average of
5.8 spacers per locus. For SGII CRISPRs, there were 20.3
loci per subject with a mean of 7.3 spacers per locus
from the cDNA, and 20.9 loci per subject with a mean
of 6.7 spacers per locus from the DNA (Additional file 1:
Table S6). The shortest loci for all subjects and CRISPR
spacer types contained 2 spacers, and the longest SGI
CRISPR locus contained 33 spacers, while the longest
SGII CRISPR locus contained 60 spacers. For the major-
ity of CRISPR loci produced, they were identical between
the DNA and the cDNA, suggesting that in most cases
the entire CRISPR locus was transcribed.
While there were relatively few spacers shared between
most subjects (Fig. 2), a few subjects did share a significant
proportion of their spacers (Additional file 2: Figure S14).
For example, subjects H7 and H9 shared 45.1 % of their
SGII spacers (Panel B), which corresponded to shared
spacers amongst 9 separate assembled loci. There also were
a significant number of SGII spacers (25.1 %) shared be-
tween subjects H7 and D4, which corresponded to shared
spacers amongst 4 different loci. There also were significant
proportions of GHI spacers shared between subjects H3
and H4, H3 and D4, H3 and D5, and H6 and D5 (Panel C);
a high proportion (31.1 %) of VSI spacers were shared be-
tween subjects H1 and D6 (Panel D).
Fig. 5 Bar graphs of the percentages (±standard deviation) of highly expressed spacers that match virome reads (Panel A) or that have
homologues in the NCBI NR database (Panel B). Highly expressed spacers are represented by white bars and all other spacers are represented by
black bars
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Fig. 6 Diagram of workflow to reconstruct CRISPR loci from short sequence reads
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different CRISPR loci to decipher whether many of the
spacers were shared as a result of separate phage expo-
sures or whether they may have been inherited as a unit.
We found several different patterns of SGI and SGII
shared spacers amongst the reassembled CRISPR loci
(Fig. 7), including: 1) loci that likely were inherited as a
unit and continued to acquire new and different spacers,
2) loci that were identical and may no longer be acquir-
ing new spacers, and 3) loci that have spacers with al-
tered order that likely were acquired through separate
exposures to similar phage.
CRISPR loci matches to virome reads
We quantified the number of CRISPR loci from all sub-
jects that had spacers with matches in the viromes of
the study subjects to determine whether there may be
biases between those loci that matched phage based on
whether they were transcribed. For SGII spacers, ap-
proximately 65 % of the reconstructed loci had no
spacers that matched any virome reads, and there was
no significant difference based on whether the locus was
transcribed (Fig. 8, Panel A). Approximately 25 % only
had single spacers that matched phage, while approxi-
mately 10 % had multiple spacers that matched phage.
These numbers were significantly different for SGI
spacers, where 85 % had no matches, 12 % had single
matches, and 3 % had multiple spacers that matched vi-
ruses. Each subject had SGI and SGII CRISPR loci with
matches to phage (Additional file 2: Figure S15), suggest-
ing that in each subject there were CRISPR loci tran-
scribed that may have been active in resistance against
these phage. That there were no significant differences
in the proportions of loci that matched phage based on
whether or not the locus was transcribed, suggests thatCRISPR-mediated resistance on a global scale is not reg-
ulated based on locus transcription.
We also tested whether the presence of spacers that
matched viruses were concentrated to individual CRISPR
loci, which might suggest that some individual loci may
be more active against circulating viruses. We measured
the proportion of CRISPR loci that only had single
spacers that matched viruses and the proportion of
CRISPR loci that had multiple matches to viruses. Inter-
estingly, there was a significant (p < 0.05) proportion of
SGII CRISPR loci that had a relatively high ratio of total
spacers to virome matches (Additional file 2: Figure
S16), suggesting that these particular loci were highly
adapted to counteracting oral viruses. Similar results
were not found for SGI spacers, however, the proportion
of CRISPR spacers that matched viruses was much lower
for SGI than SGII CRISPR spacers.
Discussion
We previously examined CRISPR spacers from the oral
cavities of human subjects using repeat-based amplifica-
tion [11, 28, 29, 34, 35], which allowed us to examine
large spacer repertoires from multiple different bacterial
species simultaneously. In those studies, we could only
characterize the presence of CRISPR spacers, but could
not assemble them into loci nor could we determine
whether or not those CRISPR loci were expressed. Here,
we provide the first characterization of CRISPR spacers
that are actively transcribed in the oral cavities of a co-
hort of human subjects, and demonstrate that the vast
majority of the spacers present are actually transcribed.
We amplified and characterized CRISPR spacers from 4
separate repeat motifs in different oral species of
Streptococcus, Gemella, and Veillonella, and most of the
spacers identified from each motif were transcribed
Fig. 7 Reassembled CRISPR loci from various subjects. Panel A shows some representative loci from SGII loci and Panel B shows some
representative loci from SGI loci. Each spacer is labeled with a unique numeric identifier for SGI and SGII. Spacers that are shared between
different subjects are shown in colors, and white boxes represent spacers that are unique to that individual subject. The loci are drawn in a
presumptive 5’ to 3’ orientation based on the end of the loci that differs between subjects
Lum et al. BMC Genomics  (2015) 16:401 Page 10 of 16(Fig. 3, Panel A). The transcription of most of these
spacers is interesting in light of a recent study that
showed tolerance to temperate phage via transcription-
dependent targeting by the CRISPR-Cas system [54].
Most of the phage identified in the viromes in this study
were predicted to have temperate lifestyles [33], which
suggests that tolerance to temperate phage may exist
even in the presence of basal CRISPR locus transcrip-
tion. Some of these transcribed loci likely belong to the
same bacteria, which supports that CRISPR-Cas systems
may function independently in some bacteria [55].
The high proportion of spacers from each different re-
peat motif that were transcribed suggests that most of
the CRISPR spacers in the oral cavity have some basal
level of transcription. These results are in support of a
prior study that showed the expression of CAS proteins
from CRISPR-Cas systems that were previously thought
to be inactive [56]. In that study, the expression of CASproteins was increased in response to phage, and our
finding of highly expressed CRISPR spacers suggests that
the transcription of these loci may also be a response to
the presence of phage. Transcription is a paramount
early step in CRISPR-mediated resistance against plas-
mids and phage, but the transcription of CRISPR loci
does not necessarily indicate CRISPR-mediated resist-
ance. Depending on the organism and the CRISPR-Cas
system type [57], other steps including the processing of
transcripts into mature crRNAs [51–53], and presence/
expression of other Cas genes [51, 58], ultimately deter-
mine whether the production of CRISPR locus transcripts
are active in mediating resistance against viruses and plas-
mids. The presence of highly expressed spacers would
suggest that there were phage present in the oral cavities
of these subjects that stimulated transcription, yet our
analysis did not demonstrate any relationship between
highly expressed spacers and matches to oral phage. There
Fig. 8 Percentage of reassembled CRISPR loci with spacers that
match virome reads. The CRISPR loci are sorted based on those loci
without matches, loci with only a single spacer that matches virome
reads, and loci with multiple spacers that match virome reads.
Transcribed loci are shown in white and those loci not identified in
transcripts are shown in black. Panel A represents SGI spacers and
Panel B represents SGII spacers
Lum et al. BMC Genomics  (2015) 16:401 Page 11 of 16are several possible explanations for this finding, including:
1) basal levels of transcription of these loci are sufficient to
counteract invading phage and plasmids, 2) transcription of
these loci may respond to other signals besides the presence
of matching phage/plasmids and 3) lesser abundant phage
that were not identified in our analysis may stimulate
CRISPR locus transcription. We believe that the relative
abundance may be very important in identifying phage that
may stimulate CRISPR locus transcription in complex com-
munities, as we found few assembled viruses in this analysis
that matched spacers, but a far greater number of virome
reads. This suggests that there were numerous viruses
present in these viromes that could not be assembled due
to a relatively low abundance or limitations in the assembly
process. A longitudinal analysis of the CRISPRs and vir-
omes may also highlight that some viruses in these com-
munities fluctuate in their relative abundance, potentially as
a result of interactions with CRISPRs.The proportion of CRISPR spacers matching viruses in
the oral cavity was relatively low, but differed significantly
by CRISPR spacer type (Fig. 3, Panel B). Both SGI and
SGII CRISPRs are found in multiple different oral strepto-
coccal species [35] and represent Type II CRISPR-Cas sys-
tems [57], yet 3x the number of SGII spacers matched oral
viruses than SGI spacers. The GHI spacers known to be
found in oral species of Gemella and the VSI spacers
found in oral species of Veillonella had many fewer
spacers matching oral viruses when compared to strepto-
coccal spacers. These data could reflect a high abundance
of streptococcal phage present in each subject, relative
abundances of different phage in the oral cavity, or poten-
tially reflect the relative activity of these different CRISPR
types in acquired resistance against oral phage. The data
for individual spacers matching phage were also reflected
in the relative proportions of reassembled CRISPR loci
containing spacers that matched oral viruses. Approxi-
mately 35 % of the reassembled SGII CRISPR loci
matched viruses, while only 15 % of SGI reassembled loci
matched viruses (Fig. 8). Despite the increased proportion
of SGII spacers matching the viruses, there was no bias
identified in transcribed loci matching viruses. In fact,
whether individual spacers or whole loci were identified in
transcripts, had no effect upon the proportion of spacers
or loci that matched viruses (Figs. 3 and 8). There also
were some SGII loci that were extraordinarily well adapted
to oral phage populations with all or nearly all their tran-
scribed spacers matching oral viruses (Additional file 2:
Figure S16). The highly individual-specific nature of the
spacer repertoires in the subjects studied (Fig. 2) likely is
related to bacterial strains present in each subject. We
believe this explains why there was no association be-
tween spacer repertoires in periodontal health or dis-
ease (Additional file 1: Table S2), and there also were no
specific patterns observed of spacers matching phage in
these subjects (Additional file 2: Figures S4 and S5).
The CRISPR-Cas system for bacteria serves the import-
ant functions of providing acquired resistance against in-
vading phage and plasmids. This study was designed to
characterize those CRISPR spacers that matched phage in
the oral cavities of the cohort of subjects; however, it could
not address whether there might exist transcription biases
against plasmids. Our prior studies have indicated that a
small proportion of SGI and SGII spacers do match
known streptococcal plasmids; however, we do not have
metagenome data for plasmids present in the oral cavities
of our subjects for comparison. We believe that the trends
seen in spacers matching phage will be similar for plas-
mids; however, further studies are necessary to demon-
strate that phenomenon.
There are several benefits of the repeat-based amplifi-
cation approach utilized to characterize CRISPR locus
expression in our study subjects. The first is that we can
Lum et al. BMC Genomics  (2015) 16:401 Page 12 of 16analyze multiple different CRISPR loci simultaneously
without knowing their genomic locations in their various
oral bacteria. Using this technique, we likely can analyze
the CRISPR loci in tens to hundreds of different oral
bacterial species rather than concentrating on a few indi-
vidual species. Second, by utilizing longer sequencing
reads, we can assemble CRISPR loci and improve our
understanding of the various loci that target human oral
viruses. While it is unlikely that we were able to assem-
ble all CRISPR loci harboring the various repeat motifs,
we were able to assemble many different loci with differ-
ent spacer content. The patterns of shared spacers
amongst the assembled loci suggests that some were
inherited as a unit and continue to diversify, some were
inherited and may no longer be diversifying, and that
others are the result of separate phage exposures (Fig. 7).
The mean number of CRISPR loci reassembled and the
mean number of spacers per locus in each subject was
highly similar for both SGI and SGII CRISPRs. Despite
those similarities, the proportion of SGI and SGII
spacers matching oral viruses was highly disparate.
There were approximately 10 % more SGII than SGI
spacers transcribed (Fig. 3, Panel B), but the proportion
of transcribed spacers of neither CRISPR type was re-
lated to matching phage (Fig. 8). Further study is needed
to evaluate whether the disparity between SGII and SGI
may be related to their activities against oral phage.
Conclusions
There are substantial repertoires of CRISPRs in the hu-
man oral cavity that likely are involved in acquired re-
sistance against oral phage. Prior studies have shown
that oral CRISPR repertoires have evolved specific adap-
tations to oral phage populations [28]. The human oral
virome is populated by numerous different bacterio-
phage genotypes [25], and many of those phage likely
are targeted by the various CRISPR types analyzed in
this study. We had very little insight into whether
CRISPR locus transcription at the community level is
adapted to local virus populations, and the data pre-
sented in this study indicated that the vast majority of
the oral CRISPR loci sampled were transcribed. The sig-
nificant proportions of loci that were transcribed indi-
cated that most were transcribed at a basal level, yet
some spacers also were highly expressed. Loci that were
highly transcribed were no more likely than others to
have spacers that matched oral phage (Fig. 8), which
could indicate that the phage to which they respond are
of low relative abundance or that the transcription of
these loci was responding to signals other than the pres-
ence of oral phage. There were no associations between
oral health status and CRISPR spacer repertoires. The
unique spacer repertoires found in all subjects suggest
that the CRISPR loci in each subject have evolved as aresult of their unique viral exposures. That many of the
CRISPR loci in the human oral cavity were transcribed
and match oral phage, suggests they may play a substan-
tial role in shaping the human oral virome.
Methods
Ethics statement
All subjects were recruited and enrolled from the Western
University College of Dental Medicine and their participa-
tion was approved by the Western University College of
Dental Medicine and the University of California, San
Diego Administrative Panels on Human Subjects in
Medical Research. All subjects signed a written informed
consent indicating their willingness to participate in this
study.
Human subjects
Each subject underwent a baseline periodontal examin-
ation that included measurements of probing depths,
clinical attachment loss, Plaque Index, Gingival Index,
and gingival irritation. We used the 1999 International
Workshop for Classification of Periodontal Diseases and
Conditions, where periodontal disease is defined by loss
of attachment. For a diagnosis of healthy, all sites had to
have an attachment level of 0 mm and an absence of bleed-
ing on probing. Each subject completed a survey self-
reporting his or her oral health, and any other pre-existing
medical conditions that could result in substantial im-
munosuppression. Exclusion criteria included antibiotic
administration during the month prior to the beginning
of the study. Each subject provided a minimum of 3 ml
of non-stimulated saliva, which was immediately frozen
at −80 °C prior to use in this study.
Amplification and binning of streptococcal CRISPR
spacers
From each subject, genomic DNA was prepared from sal-
iva using the Qiagen QIAamp DNA MINI Kit (Qiagen,
Valencia, CA), with the addition of a bead beating step
using Lysing Matrix B (MPBio, Solon, OH) prior to DNA
extraction. CRISPR sequences were amplified based on
primers designed from the palindromic repeat sequences
of various CRISPRs (Additional file 1: Table S7). Primers
pairs for SGI, SGII, GHI, and VSI CRISPR spacers contain
10-nucleotide barcode sequences (represented by the ‘X’),
and were used to amplify CRISPR sequences from each
subject (Additional file 1 Tables S7 and S8). Reaction
conditions included 44 μl Platinum High-Fidelity PCR
Mastermix (Invitrogen, Carlsbad, CA), 1 μl of each the
forward and reverse primer (10 mmol each), and 4 μl
DNA template. The following were used as cycling pa-
rameters: 2 min initial denaturation at 94 °C, followed
by 30 cycles of denaturation (15 s at 95 °C), annealing
(15 s), and extension (2 min at 72 °C), followed by a final
Lum et al. BMC Genomics  (2015) 16:401 Page 13 of 16extension (10 min at 72 °C). CRISPR amplicons were gel
extracted using the Qiagen MinElute Kit (Qiagen, Valencia,
CA). Molar equivalents were determined for each product
using an Agilent Bioanalyzer HS DNA Kit (Agilent, Santa
Clara, CA), and each were pooled into equimolar equiva-
lents. Resulting pools were sequenced on 314 chips using
an Ion Torrent PGM according to manufacturer’s instruc-
tions (Life Technologies, Grand Island, NY) [59]. Barcoded
sequences then were binned according to 100 % matching
barcodes. Each read was trimmed according to modified
Phred scores of 0.5, and low complexity reads and reads
with ambiguous characters were removed prior to further
analysis. Only those reads that had 100 % matching
sequences to both the 5’ and the 3’ end of the CRISPR
repeat motifs were used for further evaluation. Spacers
were defined as any nucleotide sequences (length ≥20)
in between repeat motifs. To group spacers according
to their trinucleotide content, we first compiled the tri-
nucleotide content for all spacers and added them to a
database. For each sequence, the difference in trinucle-
otide content was compared between all possible pairs
of sequences regardless of overall spacer length, as
length differences between identical spacers over the
length of the shorter spacer would only account for
small differences in total trinucleotide content. The
sum of the differences for all sequence pairs then was
determined, and then spacers were binned together if
their differences were less than the standard deviation
from the mean overall difference. Charts were created
that included the total number of spacers with a specified
number of trinucleotide differences (Additional file 2:
Figure S1). To validate the technique, random datasets
of spacers were created with known numbers of muta-
tions (including indels and polymorphisms). This tech-
nique was validated as previously described [29].
For each subject evaluated, a database of spacer groups
was generated, and databases were compared to determine
shared spacer groups and to create heatmaps using Java
Treeview [60]. CRISPR spacers for each subject were used
to search a database of the virome reads for matches
from all viromes combined, and the number of spacer
matches per virome read was used to create heatmaps.
Spacers from each subject were subjected to BLASTN
analysis based on the NCBI non-redundant database.
Hits were considered significant based on bit scores ≥45,
which roughly correlated to 2 nucleotide differences
over the length of a 30 nucleotide spacer. CRISPR
spacers for each subject were used to search a data-
base of the virome reads for matches from all vir-
omes combined. Matches to viromes were defined as
exact matches to any spacer sequence within any spa-
cer group. Rarefaction analysis was performed based
on spacer group richness estimates of 10,000 itera-
tions using EcoSim [61].Identification of overexpressed spacers
To identify those CRISPR spacers with high expression,
we compared the CRISPR spacer repertoires found in the
DNA fractions with those found in the cDNA. The relative
abundances of spacers in both fractions were normalized
according to their Percentage Per Thousand Spacers
(PPTS) so that the relative proportions of spacers could be
compared directly between DNA and cDNA. Spacers were
ranked according to their relative abundances in the DNA
and cDNA fractions and the ranks used as input for de-
terminations of Spearman’s rho according to the formula
1-((6-∑di
2)/n(n3-1)), where di represents the difference be-
tween the ranks and n is the total number of spacers com-
pared. We utilized the PPTS values as baseline expression
values and determined residuals by subtracting the PPTS
for cDNA from baseline. Each residual was then compared
back to the baseline value and those spacers in which the
residuals represented 3x the baseline DNA value was
considered highly expressed. Only those spacers with
baseline values of ≥5 were considered in the analysis to
determine highly expressed spacers. The distribution of
all the PPTS values for both the DNA and cDNA are
shown in Additional file 2 Figures S6, S7, S8 and S9.
CRISPR locus assembly
To assemble CRISPR loci, we binned all spacer sequences
according to their trinucleotide content. We then assigned
a unique identifier to each spacer group identified and
assigned the spacers within each read with that unique
identifier. We then compiled a database of all reads by their
unique identifiers and determined the frequency that each
combination of spacers were adjacent to one another based
on the proportion of times they could be adjacent given
their known frequencies within the dataset. For spacer
combinations that had adjacent spacers in which their
frequency was greater than 60 %, they were assembled
iteratively by matching adjacent spacers in the reads.
For most loci, the relative frequencies of adjacent
spacers within the locus were within 15 % for all spacer
combinations. For those spacer combinations in which
their frequency was <60 % but >20 %, they were assembled
manually, as in most cases they could be placed into alter-
native loci that likely represented CRISPR loci of lower
relative abundance. For each subject, the loci assembled
manually were verified by designing primers for the first
and last spacer in each locus followed by PCR amplifica-
tion. A few of the PCR amplicons also were subjected to
Sanger sequencing to ensure that their actual sequence
matched that which was reassembled from the short read
data (Additional file 2 Figures S11 and S12).
Statistical analysis
To assess whether spacer groups had significant overlap be-
tween the DNA and cDNA of each subject, we performed a
Lum et al. BMC Genomics  (2015) 16:401 Page 14 of 16permutation test. We simulated the distribution of the frac-
tion of shared spacers between different individuals and nu-
cleic acid types. For each set, we computed the summed
fraction of randomly chosen spacer groups across different
subjects and nucleic acid types, and from those computed
an empirical null distribution of statistics. The fraction
computed resulted from 10,000 iterations, and included
1000 spacer groups sampled per iteration. The standard de-
viation was computed from the percentage of shared spacer
groups over the 10,000 iterations. For each subject, an em-
pirical null distribution of statistics was determined. The
observed statistic was referred to this distribution, and the
p value was computed as the fraction of times the simu-
lated statistic for intra-subject exceeded the simulated stat-
istic for the inter-subject.
Comparisons of the mean percentages of shared
spacers and standard error rates in different subjects or
between groups of subjects were performed using
Microsoft Excel 2007 (Microsoft Corp., Redman, WA).
Statistical significance was determined by two-tail t-test
for comparison of means.Additional files
Additional file 1: Table S1. Numbers of CRISPR-bearing reads and
spacers sequenced per subject. Table S2. Estimates of shared CRISPR
spacers by oral health status or nucleic acid type. Table S3. Estimates of
shared CRISPR spacers within and between subjects. Table S4. Numbers of
CRISPR-bearing longer reads and spacers sequenced per subject. Table S5.
Reassembled SGI CRISPR loci from all subjects. Table S6. Reassembled SGII
CRISPR loci from all subjects.
Additional file 2: Figure S1. Plots of CRISPR spacer comparisons for
each CRISPR spacer type. The Y-axis represents the number of CRISPR
spacer comparisons performed and the X-axis represents the number of
trinucleotide differences. The dashed line corresponds to the statistical cutoff
for binning CRISPR spacers into spacer groups. Panel A—SGI CRISPR spacers,
Panel B—SGII CRISPR spacers, Panel C—GHI CRISPR spacers, and Panel
D—VSI CRISPR spacers. Figure S2. Rarefaction analysis of CRISPR spacer
groups in the saliva of all subjects. Rarefaction curves were created using
10,000 random iterations based on spacer group richness. The y-axis
represents the number of unique spacer groups and the x-axis represents the
number of spacers sampled. Panel A—SGI CRISPRs, Panel B—SGII CRISPRs,
Panel C—GHI CRISPRs, and Panel D—VSI CRISPRs. Periodontally healthy
subjects are shown in white and subjects with significant periodontal disease
are shown in black. Triangles represent CRISPR spacers from cDNA and circles
represent CRISPR spacers from genomic DNA. Figure S3. Estimated
percentages (± standard deviation) of CRISPR spacers shared between
genomic DNA and cDNA. Within subject comparisons are demonstrated by
black bars and between subject comparisons are demonstrated by the
white bars. Panel A—SGI CRISPR spacers, Panel B—SGII CRISPR spacers,
Panel C—GHI CRISPR spacers, and Panel D—VSI CRISPR spacers. Figure S4.
Heatmaps of SGI (Panel A) and SGII (Panel B) CRISPR spacers that match
virome reads. Virome reads from subjects with relative periodontal
health and those with periodontal disease are shown along the rows.
The columns represent the different subjects with periodontal health or
disease. Figure S5. Principal coordinates analysis of beta diversity between
subjects with CRISPR spacer matches to virome reads. Subjects with relative
periodontal health are shown by white circles and subjects with periodontal
disease are shown by black circles. Panel A—SGI CRISPRs, Panel B—SGII
CRISPRs, Panel C—GHI CRISPRs, and Panel D—VSI CRISPRs. Figure S6. Plots
of PPTS (Percentage Per Thousand Spacers) values for SGI spacers from the
DNA fractions (black diamonds) and the cDNA fractions (red boxes). ThePPTS values are shown on the y-axis and the individual spacers are shown
on the x-axis. Each box or diamond represents a different individual spacer.
Panel A—H represent subjects with relative periodontal health and Panels I-O
represent subjects with periodontal disease. Figure S7. Plots of PPTS
(Percentage Per Thousand Spacers) values for SGII spacers from the
DNA fractions (black diamonds) and the cDNA fractions (red boxes). The
PPTS values are shown on the y-axis and the individual spacers are
shown on the x-axis. Each box or diamond represents a different individual
spacer. Panel A-H represent subjects with relative periodontal health and
Panels I-O represent subjects with periodontal disease. Figure S8. Plots of
PPTS (Percentage Per Thousand Spacers) values for GHI spacers from the
DNA fractions (black diamonds) and the cDNA fractions (red boxes). The
PPTS values are shown on the y-axis and the individual spacers are shown
on the x-axis. Each box or diamond represents a different individual spacer.
Panel A-H represent subjects with relative periodontal health and Panels I-O
represent subjects with periodontal disease. Figure S9. Plots of PPTS
(Percentage Per Thousand Spacers) values for VSI spacers from the DNA
fractions (black diamonds) and the cDNA fractions (red boxes). The PPTS
values are shown on the y-axis and the individual spacers are shown on
the x-axis. Each box or diamond represents a different individual spacer.
Panel A-H represent subjects with relative periodontal health and Panels
I-O represent subjects with periodontal disease. Figure S10. Bar plots of
the percentages (± standard deviation) of CRISPR spacers that are highly
expressed. The x-axis represents the CRISPR spacer type and the y-axis
represents the percentage of all spacers. Figure S11. Sequence of
reassembled CRISPR locus from healthy subject H5. Figure S12.
Sequence of reassembled CRISPR locus from subject D1 with periodontal
disease. Figure S13. Rarefaction analysis of CRISPR spacer groups from
200bp reads in the saliva of all subjects. Figure S14. CRISPR spacer group
heat matrices demonstrating the percentage of shared CRISPR spacer
groups between all subjects. The top triangular portion of each matrix
represents comparisons between CRISPR spacers derived from subjects
with relative periodontal health, the bottom rectangular portion of each
matrix represents comparisons between periodontal health-derived and
periodontal disease-derived CRISPR spacers, and the bottom triangular
portion of each matrix represents comparisons between periodontal
disease-derived CRISPR spacers. The intensity scale bar is located to the
right. Panel A—SGI, Panel B—SGII, Panel C—GHI, and Panel D—VSI
CRISPR spacers. Figure S15. Percentage of reassembled CRISPR loci with
spacers that match virome reads for subjects with periodontal health
and disease. Figure S16. Ratio of CRISPR spacer matches to total spacer
counts in reassembled loci. The ratio of matches to spacer counts is
shown for loci with multiple spacers that match viromes (white boxes)
and for those with only single spacers that match virome reads (black
boxes). The mean ratio for all loci from all subjects is indicated by the
black bar. SGII CRISPR loci are located on the left, and SGI loci are located on
the right.
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